HMOX1 and hepatocellular carcinoma: HO-1 also elicits anti-ferroptotic effects in hepatocellular carcinoma (HCC) cells since Nrf2 activation inhibits ferroptosis via p62-mediated Keap1 degradation, upregulating the actions of Nrf2 on its target genes, HO-1 and FTH1 [36].